137 related articles for article (PubMed ID: 7160537)
1. Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin-diabetic rat.
Greene DA; Lewis RA; Lattimer SA; Brown MJ
Diabetes; 1982 Jul; 31(7):573-8. PubMed ID: 7160537
[TBL] [Abstract][Full Text] [Related]
2. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
Tomlinson DR; Mayer JH
Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
[TBL] [Abstract][Full Text] [Related]
3. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA
Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
[TBL] [Abstract][Full Text] [Related]
4. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
5. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.
Sonobe M; Yasuda H; Hisanaga T; Maeda K; Yamashita M; Kawabata T; Kikkawa R; Taniguchi Y; Shigeta Y
Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681
[TBL] [Abstract][Full Text] [Related]
7. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.
Greene DA; Lattimer SA
J Clin Invest; 1983 Sep; 72(3):1058-63. PubMed ID: 6309904
[TBL] [Abstract][Full Text] [Related]
8. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
9. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve.
Sonobe M; Yasuda H; Hatanaka I; Terada M; Yamashita M; Kikkawa R; Shigeta Y
Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630
[No Abstract] [Full Text] [Related]
10. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats.
Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Komori H; Sakamoto N
Diabetes; 1992 May; 41(5):587-91. PubMed ID: 1533192
[TBL] [Abstract][Full Text] [Related]
11. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
[TBL] [Abstract][Full Text] [Related]
12. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.
Whiteley SJ; Tomlinson DR
Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601
[TBL] [Abstract][Full Text] [Related]
13. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity.
Hirata Y; Okada K
Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992
[TBL] [Abstract][Full Text] [Related]
14. Reduced Na+/K+ adenosine triphosphatase activity and motor nerve conduction velocity in L-fucose-fed rats is reversible after dietary normalization.
Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Conner CE
Metabolism; 1996 Feb; 45(2):229-34. PubMed ID: 8596495
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
[TBL] [Abstract][Full Text] [Related]
16. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes on motor conduction velocity in different branches of the rat sciatic nerve.
Cameron NE; Cotter MA; Harrison J
Exp Neurol; 1986 Jun; 92(3):757-61. PubMed ID: 2940110
[TBL] [Abstract][Full Text] [Related]
18. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro.
Kim J; Kyriazi H; Greene DA
Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704
[TBL] [Abstract][Full Text] [Related]
19. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol.
Kim J; Rushovich EH; Thomas TP; Ueda T; Agranoff BW; Greene DA
Diabetes; 1991 Nov; 40(11):1545-54. PubMed ID: 1657670
[TBL] [Abstract][Full Text] [Related]
20. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
Yasuda H; Sonobe M; Hatanaka I; Yamashita M; Miyamoto Y; Terada M; Amenomori M; Kikkawa R; Shigeta Y; Motoyama Y
Biochem Biophys Res Commun; 1988 Jan; 150(1):225-30. PubMed ID: 3276309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
